Optimization of Therapy for Severe Aplastic Anemia Based on Clinical, Biologic, and Treatment Response Parameters: Conclusions of an International Working Group on Severe Aplastic Anemia Convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010-Reference-Cited by-同舟云学术

Optimization of Therapy for Severe Aplastic Anemia Based on Clinical, Biologic, and Treatment Response Parameters: Conclusions of an International Working Group on Severe Aplastic Anemia Convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010

Published:2011-03 Issue:3 Volume:17 Page:291-299
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Pulsipher Michael A.,Young Neal S.,Tolar Jakub,Risitano Antonio M.,Deeg H. Joachim,Anderlini Paolo,Calado Rodrigo,Kojima Seiji,Eapen Mary,Harris Richard,Scheinberg Phillip,Savage Sharon,Maciejewski Jaroslaw P.,Tiu Ramon V.,DiFronzo Nancy,Horowitz Mary M.,Antin Joseph H.

Funder

Blood and Marrow Transplant Clinical Trials Network

National Heart, Lung, and Blood Institute

National Cancer Institute

Genzyme

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference49 articles.

1. The epidemiology of aplastic anemia in Thailand;Issaragrisil;Blood,2006

2. Current concepts in the pathophysiology and treatment of aplastic anemia;Young;Blood,2006